These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30636486)

  • 1. Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation.
    Apaijai N; Moisescu DM; Palee S; McSweeney CM; Saiyasit N; Maneechote C; Boonnag C; Chattipakorn N; Chattipakorn SC
    J Am Heart Assoc; 2019 Jan; 8(2):e010838. PubMed ID: 30636486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil provides neuroprotective effects against brain injury and Alzheimer's pathology under conditions of cardiac ischemia/reperfusion injury.
    Ongnok B; Khuanjing T; Chunchai T; Kerdphoo S; Jaiwongkam T; Chattipakorn N; Chattipakorn SC
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165975. PubMed ID: 32956775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin preferentially provides neuroprotection following cardiac ischemia/reperfusion in non-diabetic rats.
    Benjanuwattra J; Apaijai N; Chunchai T; Kerdphoo S; Jaiwongkam T; Arunsak B; Wongsuchai S; Chattipakorn N; Chattipakorn SC
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165893. PubMed ID: 32621957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute administration of metformin prior to cardiac ischemia/reperfusion injury protects brain injury.
    Leech T; Apaijai N; Palee S; Higgins LA; Maneechote C; Chattipakorn N; Chattipakorn SC
    Eur J Pharmacol; 2020 Oct; 885():173418. PubMed ID: 32750367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study.
    Ko DT; Khan AM; Kotrri G; Austin PC; Wijeysundera HC; Koh M; Chu A; Jackevicius CA; Lawler PR; Tu JV
    J Am Heart Assoc; 2018 Nov; 7(21):e010007. PubMed ID: 30571382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury.
    Liao S; Luo Y; Chunchai T; Singhanat K; Arunsak B; Benjanuwattra J; Apaijai N; Chattipakorn N; Chattipakorn SC
    Inflamm Res; 2022 Aug; 71(7-8):861-872. PubMed ID: 35655102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute administration of myeloid differentiation factor 2 inhibitor and N-acetyl cysteine attenuate brain damage in rats with cardiac ischemia/reperfusion injury.
    Vongsfak J; Apaijai N; Chunchai T; Pintana H; Arunsak B; Maneechote C; Singhanat K; Wu D; Liang G; Chattipakorn N; Chattipakorn SC
    Arch Biochem Biophys; 2023 May; 740():109598. PubMed ID: 37054769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Fusion Promoter Alleviates Brain Damage in Rats with Cardiac Ischemia/Reperfusion Injury.
    Surinkaew P; Apaijai N; Sawaddiruk P; Jaiwongkam T; Kerdphoo S; Chattipakorn N; Chattipakorn SC
    J Alzheimers Dis; 2020; 77(3):993-1003. PubMed ID: 32804148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanin Exerts Neuroprotection During Cardiac Ischemia-Reperfusion Injury.
    Kumfu S; Charununtakorn ST; Jaiwongkam T; Chattipakorn N; Chattipakorn SC
    J Alzheimers Dis; 2018; 61(4):1343-1353. PubMed ID: 29376862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury.
    Liao S; Apaijai N; Luo Y; Wu J; Chunchai T; Singhanat K; Arunsak B; Benjanuwattra J; Chattipakorn N; Chattipakorn SC
    Cell Death Discov; 2021 Oct; 7(1):312. PubMed ID: 34689160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid-lowering effects.
    Palee S; McSweeney CM; Maneechote C; Moisescu DM; Jaiwongkam T; Kerdphoo S; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2019 Nov; 23(11):7310-7319. PubMed ID: 31557388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Fusion Promoter Given During Ischemia Has Greater Neuroprotective Efficacy Than When Given at Onset of Reperfusion in Rats with Cardiac Ischemia/Reperfusion Injury.
    Chunchai T; Apaijai N; Janjek S; Arunsak B; Nipon C; Chattipakorn SC
    J Alzheimers Dis; 2024; 97(1):205-217. PubMed ID: 38043015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCSK9 inhibition protects against myocardial ischemia-reperfusion injury via suppressing autophagy.
    Huang G; Lu X; Zhou H; Li R; Huang Q; Xiong X; Luo Z; Li W
    Microvasc Res; 2022 Jul; 142():104371. PubMed ID: 35460665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destructive Effects of Pyroptosis on Homeostasis of Neuron Survival Associated with the Dysfunctional BBB-Glymphatic System and Amyloid-Beta Accumulation after Cerebral Ischemia/Reperfusion in Rats.
    Lyu Z; Chan Y; Li Q; Zhang Q; Liu K; Xiang J; Li X; Cai D; Li Y; Wang B; Yu Z
    Neural Plast; 2021; 2021():4504363. PubMed ID: 34434229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCSK9 Knockdown Can Improve Myocardial Ischemia/Reperfusion Injury by Inhibiting Autophagy.
    Huang G; Lu X; Duan Z; Zhang K; Xu L; Bao H; Xiong X; Lin M; Li C; Li Y; Zhou H; Luo Z; Li W
    Cardiovasc Toxicol; 2022 Dec; 22(12):951-961. PubMed ID: 36342620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanin prevents brain mitochondrial dysfunction in a cardiac ischaemia-reperfusion injury model.
    Kumfu S; Charununtakorn ST; Jaiwongkam T; Chattipakorn N; Chattipakorn SC
    Exp Physiol; 2016 Jun; 101(6):697-707. PubMed ID: 27059110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Development of Novel 1,3,5-Triazine-Procaine Derivatives as Protective Agent against Myocardial Ischemia/Reperfusion Injury via Inhibitor of Nuclear Factor-κB.
    Qiang Z; Yu W; Yu Y
    Pharmacology; 2019; 104(3-4):126-138. PubMed ID: 31212291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of lycopene in targeting proprotein convertase subtilisin/kexin type-9 to combat hypercholesterolemia.
    Sultan Alvi S; Ansari IA; Khan I; Iqbal J; Khan MS
    Free Radic Biol Med; 2017 Jul; 108():394-403. PubMed ID: 28412198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy.
    Di Minno A; Gentile M; Iannuzzo G; Calcaterra I; Tripaldella M; Porro B; Cavalca V; Di Taranto MD; Tremoli E; Fortunato G; Rubba POF; Di Minno MND
    Thromb Res; 2020 Oct; 194():229-236. PubMed ID: 33213848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury.
    Chunchai T; Apaijai N; Benjanuwattra J; Pintana H; Singhanat K; Arunsak B; Chattipakorn N; Chattipakorn SC
    Curr Res Pharmacol Drug Discov; 2022; 3():100124. PubMed ID: 36568264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.